These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9706732)

  • 1. Topiramate: pharmacokinetics and pharmacodynamics.
    Schneiderman JH
    Can J Neurol Sci; 1998 Aug; 25(3):S3-5. PubMed ID: 9706732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions of topiramate.
    Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S
    Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of topiramate: a review.
    Garnett WR
    Epilepsia; 2000; 41(S1):61-5. PubMed ID: 10768303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
    Shank RP; Maryanoff BE
    CNS Neurosci Ther; 2008; 14(2):120-42. PubMed ID: 18482025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacy clinics. Medication of the month. Topiramate (Topamax)].
    Sadzot B
    Rev Med Liege; 2000 Feb; 55(2):114-6. PubMed ID: 10769582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacological and clinical review on topiramate, a new antiepileptic drug.
    Perucca E
    Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug.
    Doose DR; Walker SA; Gisclon LG; Nayak RK
    J Clin Pharmacol; 1996 Oct; 36(10):884-91. PubMed ID: 8930774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
    Rosenfeld WE
    Clin Ther; 1997; 19(6):1294-308. PubMed ID: 9444441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine.
    Perucca E; Bialer M
    Clin Pharmacokinet; 1996 Jul; 31(1):29-46. PubMed ID: 8827398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
    Johannessen SI
    Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald DL
    Epilepsy Res; 2014 Jul; 108(5):891-901. PubMed ID: 24725807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction profile of topiramate.
    Bourgeois BF
    Epilepsia; 1996; 37 Suppl 2():S14-S17. PubMed ID: 8641241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.
    Shank RP; Gardocki JF; Streeter AJ; Maryanoff BE
    Epilepsia; 2000; 41(S1):3-9. PubMed ID: 10768292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of topiramate in the beagle dog.
    Streeter AJ; Stahle PL; Holland ML; Pritchard JF; Takacs AR
    Drug Metab Dispos; 1995 Jan; 23(1):90-3. PubMed ID: 7720530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway.
    Andreou AP; Goadsby PJ
    Cephalalgia; 2011 Oct; 31(13):1343-58. PubMed ID: 21893557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Epilepsy Res; 2014 Nov; 108(9):1519-32. PubMed ID: 25219351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.